PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first... by Andrei Gurau, Suguru Yamauchi, Kaitlyn Ecoff, Kristen P. Rodgers, James R. Eshleman, Charles Conover Talbot Jr, Peng Huang, Joshua Choi, Patrick M. Forde, Valsamo Anagnostou, Malcolm Brock, Yuping Mei

Get full text

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer by Drew M Pardoll, Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, David Jones, Taha Merghoub, Suzanne Topalian, Gary Rosner, Valsamo Anagnostou, Hok Yee Chan, Franco Verde, Daphne Wang, Matthew D Hellmann, Victor E Velculescu, James R White, Tricia R Cottrell, Joshua E Reuss, Stephen Broderick, Kellie N Smith, Marianna Zahurak, Mara Lanis, Joseph C Murray, Caroline McCarthy, Richard Battafarano, Errol Bush, Malcolm Brock, Jinny Ha, Janis Taube, Peter Illei, Ben Levy, Jamie E Chaft

Get full text